| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 3 |
| 1 | CARBOPLATIN | 2 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 3 | LANSOPRAZOLE | 2 |
| 4 | OMEPRAZOLE MAGNESIUM | 2 |
| 5 | PACLITAXEL | 2 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 7 | PANTOPRAZOLE SODIUM | 2 |
| 8 | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | 2 |
| 9 | PANTOPRAZOLE SODIUM INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 1 | TEZEPELUMAB-EKKO | 1 | 0.0001 |
| 2 | REGORAFENIB | 1 | 0.0001 |
| 3 | LOPERAMIDE HCL | 1 | 0.0001 |
| 4 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| 5 | GENTAMICIN SULFATE | 1 | 0.0001 |
| 6 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | ISOSORBIDE DINITRATE | 1 | 0.0001 |
| 8 | ERYTHROPOIETIN | 1 | 0.0000 |
| 9 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |